{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:48:49Z","timestamp":1760298529683},"reference-count":33,"publisher":"Japan Society for Clinical Immunology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2012]]},"DOI":"10.2177\/jsci.35.129","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T06:45:44Z","timestamp":1337841944000},"page":"129-135","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of Neuromyelitis Optica"],"prefix":"10.2177","volume":"35","author":[{"given":"Kazuo","family":"FUJIHARA","sequence":"first","affiliation":[{"name":"Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17551-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S. &amp; Hinson, S. R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. <i>J Exp Med<\/i> <b>202<\/b> : 473-477, 2005.","DOI":"10.1084\/jem.20050304"},{"key":"3"},{"key":"4","unstructured":"4) Takahashi, T., et al. : Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO : a study on antibody titre. <i>Brain<\/i> <b>130<\/b> : 1235-1243, 2007."},{"key":"5","unstructured":"6) Nakamura M, et al. : Preferential spinal central gray matter involvement in neuromyelitis optica : an MRI study. <i>J Neurol<\/i>, <b>255<\/b> : 163-170, 2008."},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000183151.19351.82"},{"key":"7","unstructured":"8) Takahashi T, Miyazawa I, Misu T, Takano R, Nakashima I, Fujihara K, Tobita M, Itoyama Y. : Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody : a herald of acute exacerbations. <i>J Neurol Neurosurg Psychiatry<\/i>, <b>79<\/b> : 1075-1078, 2008."},{"key":"8","unstructured":"9) Baba T, Nakashima I, Kanbayashi T, Konno M, Takahashi T, Fujihara K, Misu T, Takeda A, Shiga Y, Ogawa H, Itoyama Y. : Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody. <i>J Neurol<\/i>, <b>256<\/b> : 287-288, 2009."},{"key":"9","doi-asserted-by":"crossref","unstructured":"10) Nakamura M, Misu T, Fujihara K, Miyazawa I, Nakashima I, Takahashi T, Watanabe S, Itoyama Y. Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. <i>Mult Scler<\/i>, <b>15<\/b> : 695-700, 2009.","DOI":"10.1177\/1352458509103301"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000216139.44259.74"},{"key":"11","unstructured":"12) Waters PJ, et al. : Serologic diagnosis of NMO : A multicenter comparison of aquaporin-4-IgG assays. <i>Neurology<\/i> ; <b>78<\/b> : 665-671, 2012."},{"key":"12","unstructured":"14) Misu T, Fujihara K, Nakamura M, Murakami K, Endo M, Konno H, et al. : Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica : a case report. <i>Tohoku J Exp Med<\/i> <b>209<\/b> : 269-275, 2006."},{"key":"13","unstructured":"15) Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, et al. : Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. <i>Brain<\/i> <b>130<\/b> : 1194-1205, 2007."},{"key":"14","unstructured":"16) Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, et al. : Loss of aquaporin-4 in lesions of neuromyelitis optica : distinction from multiple sclerosis. <i>Brain<\/i> <b>130<\/b> : 1224-34, 2007."},{"key":"15","unstructured":"17) Misu T, Takano R, Fujihara K, Takahashi T, Sato S, Itoyama Y. : Marked Increase of CSF GFAP in neuromyelitis optica&mdash;an astrocytic damage marker. <i>J Neurol Neurosurg Psychiatry<\/i> <b>80<\/b> : 575-577, 2009."},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181e2414b"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000289761.64862.ce"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0b013e32832776f4"},{"key":"19","unstructured":"21) Kinoshita M, Nakatsuji Y, Kimura T, et al. : Neuromyelitis optica : passive transfer to rats by human immunoglobulin. <i>Biochem Biophys Res Commun<\/i> <b>386<\/b> : 623-627, 2009."},{"key":"20","unstructured":"22) Bennett JL, Lam C, Kalluri SR, et al. : Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. <i>Ann Neurol<\/i> <b>66<\/b> : 617-629, 2009."},{"key":"21","unstructured":"23) Bradl M, Misu T, Takahashi T, et al. : Neuromyelitis optica : pathogenicity of patient immunoglobulin in vivo. <i>Ann Neurol<\/i> <b>66<\/b> : 630-643, 2009."},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.02.157"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181a82621"},{"key":"24","unstructured":"26) Uzawa, A., et al. : Cytokine and chemokine profiles in neuromyelitis optica : significance of interleukin-6. <i>Mult Scler<\/i> <b>16<\/b> : 1443-1452, 2010."},{"key":"25","unstructured":"28) Kim W, Kim SH, Nakashima I, Takai Y, Fujihara K, Leite MI, Kitley J, Palace J, Santos E, Coutinho E, Silva AM, Kim BJ, Kim BJ, Ahn SW, Kim HJ. : Influence of pregnancy on neuromyelitis optica spectrum disorder. <i>Neurology<\/i> in press."},{"key":"26","unstructured":"30) Sato D, Callegaro D, Lana-Peixoto MA, Fujihara K on behalf of BCTRIMS. : Treatment of neuromyelitis optica, an evidence based review. <i>Arq Neuropsiquiatr<\/i> in press."},{"key":"27","unstructured":"31) Watanabe S, Nakashima I, Misu T, Miyazawa I, Shiga Y, Fujihara K, Itoyama Y. : Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. <i>Mult Scler<\/i>, <b>13<\/b> : 128-132, 2007."},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318207b1f6"},{"key":"29","unstructured":"33) Jacob, A., et al. : Treatment of neuromyelitis optica with rituximab : retrospective analysis of 25 patients. <i>Arch Neurol<\/i> <b>65<\/b> : 1443-1448, 2008."},{"key":"30","unstructured":"34) An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica [online]. Available at : http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00904826. Accessed July, 20th 2011."},{"key":"31","unstructured":"35) Tanaka, M., Tanaka, K. &amp; Komori, M. : Interferon-beta(1b) treatment in neuromyelitis optica. <i>Eur Neurol<\/i> <b>62<\/b> : 167-170, 2009."},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh453"},{"key":"33","unstructured":"37) 25. Axtell, R.C., et al. : T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. <i>Nat Med<\/i> <b>16<\/b> : 406-412, 2010."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/35\/2\/35_2_129\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:49:02Z","timestamp":1621486142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/35\/2\/35_2_129\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.35.129","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}